Literature DB >> 11446362

Trends in ciprofloxacin nonsusceptibility and levofloxacin resistance among Streptococcus pneumoniae isolates in North America.

J A Karlowsky, L Nealy, D F Sahm, C Thornsberry, M E Jones.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11446362      PMCID： PMC88231          DOI： 10.1128/JCM.39.7.2748-2750.2001

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  10 in total

1.  Fluoroquinolone resistance in Streptococcus pneumoniae.

Authors:  D E Peterson; D F Sahm
Journal:  N Engl J Med       Date:  1999-11-11       Impact factor: 91.245

2.  Macrolide and fluoroquinolone (levofloxacin) resistances among Streptococcus pneumoniae strains: significant trends from the SENTRY Antimicrobial Surveillance Program (North America, 1997-1999).

Authors:  R N Jones; M A Pfaller
Journal:  J Clin Microbiol       Date:  2000-11       Impact factor: 5.948

3.  Need for annual surveillance of antimicrobial resistance in Streptococcus pneumoniae in the United States: 2-year longitudinal analysis.

Authors:  D F Sahm; J A Karlowsky; L J Kelly; I A Critchley; M E Jones; C Thornsberry; Y Mauriz; J Kahn
Journal:  Antimicrob Agents Chemother       Date:  2001-04       Impact factor: 5.191

4.  Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study.

Authors:  P L Ho; W S Tse; K W Tsang; T K Kwok; T K Ng; V C Cheng; R M Chan
Journal:  Clin Infect Dis       Date:  2001-02-28       Impact factor: 9.079

5.  Analysis of ciprofloxacin activity against Streptococcus pneumoniae after 10 years of use in the United States.

Authors:  D F Sahm; D E Peterson; I A Critchley; C Thornsberry
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

Review 6.  In vitro activity of newer fluoroquinolones for respiratory tract infections and emerging patterns of antimicrobial resistance: data from the SENTRY antimicrobial surveillance program.

Authors:  R N Jones; M A Pfaller
Journal:  Clin Infect Dis       Date:  2000-08       Impact factor: 9.079

7.  Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

Authors:  D K Chen; A McGeer; J C de Azavedo; D E Low
Journal:  N Engl J Med       Date:  1999-07-22       Impact factor: 91.245

8.  Comparative antimicrobial activity of trovafloxacin tested against 3049 Streptococcus pneumoniae isolates from the 1997-1998 respiratory infection season.

Authors:  R N Jones; M A Pfaller; G V Doern
Journal:  Diagn Microbiol Infect Dis       Date:  1998-10       Impact factor: 2.803

9.  Bacterial pathogens isolated from patients with bloodstream infection: frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997).

Authors:  M A Pfaller; R N Jones; G V Doern; K Kugler
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

10.  Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study Group.

Authors:  G G Zhanel; J A Karlowsky; L Palatnick; L Vercaigne; D E Low; D J Hoban
Journal:  Antimicrob Agents Chemother       Date:  1999-10       Impact factor: 5.191
  10 in total
  2 in total

1.  Ciprofloxacin-resistant Escherichia coli in hospital wastewater of Bangladesh and prediction of its mechanism of resistance.

Authors:  Farhima Akter; M Ruhul Amin; Khan Tanjid Osman; M Nural Anwar; M Manjurul Karim; M Anwar Hossain
Journal:  World J Microbiol Biotechnol       Date:  2011-09-09       Impact factor: 3.312

2.  Telithromycin- and fluoroquinolone-resistant Streptococcus pneumoniae in Taiwan with high prevalence of resistance to macrolides and beta-lactams: SMART program 2001 data.

Authors:  Po-Ren Hsueh; Lee-Jene Teng; Tsu-Lan Wu; Dine Yang; Wen-Kuei Huang; Jainn-Ming Shyr; Yin-Ching Chuang; Jen-Hsien Wan; Jing-Jou Yan; Jang-Jih Lu; Jiunn-Jong Wu; Wen-Chien Ko; Feng-Yee Chang; Yi-Chueh Yang; Yeu-Jun Lau; Yung-Ching Liu; Chun-Ming Lee; Hsieh-Shong Leu; Cheng-Yi Liu; Kwen-Tay Luh
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.